Skip to main content

Augen Loosens the Tie and Sizes Up a Startup

Premium

“You’re probably wondering why I did this,” says Jeff Augen, speaking about his recent decision to leave a cushy post as worldwide director of strategy for IBM’s life science unit for his new job as president of New Haven, Conn.-based TurboWorx.

It turns out that, even post-dot-com crash, startup fever is contagious: While working with the smaller company under an alliance the two firms formed in the spring, Augen, whose previous experience was at EDS and Compaq, says he was simply won over by the company’s potential and felt the urge “to do something more entrepreneurial.”

Now splitting his time between Turbo- Worx (formerly TurboGenomics), a new post as entrepreneur-in-residence at investment bank Trautman, Wasserman & Co., and writing a textbook on post-genomic computational biology for science publisher Addison-Wesley, Augen says, “the first week has been pretty interesting.”

While running lean and keeping the company’s burn rate down, “we don’t plan to keep the revenue small,” he says. Sizing up the market for the type of parallelized workflow management software TurboWorx provides at “tens of billions of dollars,” Augen says he expects the company to capture “a few percent share of that market,” reaching the hundred-million-dollar range within the next five years — and that getting there will involve implementing key aspects of the IBM credo, such as forging partnerships rather than doing everything in-house.

— Bernadette Toner

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.